Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment,Leukemia

当前位置： X-MOL 学术 › Leukemia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment
Leukemia ( IF 12.8 ) Pub Date : 2024-01-11 , DOI: 10.1038/s41375-023-02127-0
Gerulf Hänel _{1,

2} , Anne Schönle ₃ , Anne-Sophie Neumann _{1,

2} , Daniel Nixdorf _{1,

2} , Nora Philipp _{1,

2} , Monika Sponheimer _{1,

2} , Alexandra Leutbecher _{1,

2} , Alica-Joana Emhardt ₁ , Giulia Magno ₁ , Veit Bücklein _{1,

2} , Jan Eckmann ₄ , Diana Dunshee ₅ , Vesna Kramar ₃ , Koorosh Korfi ₃ , Sara Colombetti ₃ , Pablo Umaña ₃ , Christian Klein ₃ , Marion Subklewe _{1,

2,

6}

Affiliation